Feasibility of multiplex quantum dot stain using primary antibodies from four distinct host animals
暂无分享,去创建一个
Jonathan K. Tran | Elena N. Hubbard | Todd H. Stokes | Richard A. Moffitt | May D. Wang | R. Moffitt | T. Stokes | Jonathan K. Tran | May D. Wang
[1] Shuming Nie,et al. Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. , 2010, ACS nano.
[2] Dar-Ren Chen,et al. The Potential Utility of Curcumin in the Treatment of HER-2-Overexpressed Breast Cancer: An In Vitro and In Vivo Comparison Study with Herceptin , 2011, Evidence-based complementary and alternative medicine : eCAM.
[3] Shuming Nie,et al. Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry , 2007, Nature Protocols.
[4] Yachna Sharma,et al. Simple quantification of multiplexed Quantum Dot staining in clinical tissue samples , 2008, 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[5] Shuming Nie,et al. In Situ Molecular Profiling of Breast Cancer Biomarkers with Multicolor Quantum Dots , 2007 .
[6] R. Saxena,et al. ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective , 2012, Medicinal research reviews.
[7] Sunjoo Jeong,et al. In vitro selection of RNA aptamer and specific targeting of ErbB2 in breast cancer cells. , 2011, Nucleic acid therapeutics.
[8] Ahmedin Jemal,et al. Breast cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.